Syndax Pharmaceuticals
SNDX
#6582
Rank
โ‚ฌ0.71 B
Marketcap
7,95ย โ‚ฌ
Share price
-4.49%
Change (1 day)
-47.51%
Change (1 year)

Earnings for Syndax Pharmaceuticals (SNDX)

Earnings in 2026 (TTM): -โ‚ฌ0.19 Billion

According to Syndax Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.28 Billion. In 2025 the company made an earning of -โ‚ฌ0.27 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Syndax Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.19 Billion-30.18%
2025 -โ‚ฌ0.27 Billion-10.46%
2024 -โ‚ฌ0.3 Billion52.25%
2023 -โ‚ฌ0.2 Billion40.19%
2022 -โ‚ฌ0.14 Billion-699.13%
2021 โ‚ฌ22.72 M-134.07%
2020 -โ‚ฌ66.7 Million30.53%
2019 -โ‚ฌ51.1 Million-24.22%
2018 -โ‚ฌ67.43 Million21.64%
2017 -โ‚ฌ55.43 Million36.72%
2016 -โ‚ฌ40.55 Million84.39%
2015 -โ‚ฌ21.99 Million21.64%
2014 -โ‚ฌ18.08 Million39.92%
2013 -โ‚ฌ12.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA